Suzhou Fushilai Pharmaceutical Co Ltd
301258
Company Profile
Business description
Suzhou Fushilai Pharmaceutical Co Ltd is engaged in the Research and development, production and sales of pharmaceutical intermediates, APIs and raw materials for health care products. The products are mainly used in the fields of medicine, dietary supplements and cosmetics, and have important effects in anti-oxidation, anti-aging, and blood sugar improvement.
Contact
No. 16, Haiwang Road
New Material Industrial Park, Jiangsu Province
Changshu215500
CHNT: +86 51252015605
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
524
Stocks News & Analysis
stocks
10 best global blue-chip stocks to buy for the long term
The stocks of these high-quality companies with large market capitalizations look undervalued today.
stocks
3 overvalued ASX shares going into earnings
Prices of these shares exceed our Fair Value Estimate by more than double.
stocks
The long-term case for compounders
Compounders tend to deliver steadier, more durable profit growth across full cycles, making them better suited for long-term investors.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,068.80 | 42.20 | -0.46% |
| CAC 40 | 8,187.24 | 60.71 | 0.75% |
| DAX 40 | 24,798.53 | 259.72 | 1.06% |
| Dow JONES (US) | 49,245.55 | 353.08 | 0.72% |
| FTSE 100 | 10,314.85 | 91.31 | 0.89% |
| HKSE | 26,775.57 | 611.54 | -2.23% |
| NASDAQ | 23,609.62 | 147.80 | 0.63% |
| Nikkei 225 | 52,655.18 | 667.67 | -1.25% |
| NZX 50 Index | 13,412.44 | 10.74 | -0.08% |
| S&P 500 | 6,971.07 | 32.04 | 0.46% |
| S&P/ASX 200 | 8,778.60 | 42.50 | -0.48% |
| SSE Composite Index | 4,015.75 | 102.20 | -2.48% |